ArticleSkin appendage disorders2026
Opioid Prescribing Patterns Associated with Selective Matrixectomies for Toenail Onychocryptosis: A TriNetX Analysis.
Article in Skin appendage disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Selective matrixectomy is a common intervention for painful onychocryptosis that is associated with mild-to-moderate postoperative pain. It can usually be managed effectively with non-opioid analgesics. We evaluated rates and factors associated with opioid prescribing following selective matrixectomy to guide physicians in counseling postoperative patients. Methods: A retrospective cohort study was conducted using the TriNetX research network, querying for patients who underwent selective matrixectomy for onychocryptosis. Opioid prescriptions <3 days after selective matrixectomy were assessed, and Cox regression estimated hazard ratios and 95% confidence intervals for opioid prescribing, adjusting for factors associated with prolonged opioid use. Results: Among 97,208 patients who underwent selective matrixectomy, 14,759 received an opioid prescription <3 days postoperatively (15.2%), declining from 24.3% during 2008-2018 to 12.8% during 2018-2025. Female sex, older age, Asian race, antidepressant use, and histories of anxiety, depression, chronic pain, migraine, osteoarthritis, and back pain were associated with lower likelihood of opioid prescribing. Black/African American race, Hispanic/Latino ethnicity, prior benzodiazepine or opioid use, and fibromyalgia were associated with higher likelihood. Conclusion: Opioid prescribing following selective matrixectomy was relatively common and may be more frequent than clinically necessary. Prescribing patterns appear influenced by demographic and clinical factors, suggesting an opportunity to refine postoperative pain management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.